Two experts will share their insights and expertise at a free and open-to-the-public event, “Teaching our Kids and Teens Success through Resiliency.” Both Dr. Cypers and Dr. Wamboldt have specialties in adolescent and family dynamics, with an emphasis on anxiety and stress.
This month in NE Updates: Measles Outbreak in Stapleton; Trampoline & Adventure Park Coming to Stapleton; and I-70 Construction Update.
Each month, the Indie Prof reviews a current film in the theater and second film or series available on DVD or instant-streaming service. Follow “Indie Prof” on Facebook for updates about film events and more reviews.
How often during the holiday season have you said, “We should give back this year. Let’s go feed the homeless.”
In the U.S., an estimated 4.6 million children live in homes with guns that are loaded and not secured, according to Everytown for Gun Safety.
After a long wait for a written agreement, The Urban Farm is excited its official partnership with the City of Denver is about to begin.
Each month, the Indie Prof reviews a current film in the theater and second film or series available on DVD or instant-streaming service. Follow “Indie Prof” on Facebook for updates about film events and more reviews.
Amy Klin knows what parents are going through. She’s been there, done that, freaked out about it and figured a better way to deal with it.
This month’s letters: DPS official explains methodology for number of new middle school seats needed. Inspire PTO President writes concerns about number of seats and transparency. A reader gives his reasons for supporting Proposition 112 on the upcoming ballot.
On October 31, as much of our community is trick-or-treating, some among us will be thinking of their departed loved ones and preparing to celebrate All Souls’ Day—the Day of the Dead.
What do local families want to see in a new local middle school? That’s the question on the minds of three school leaders vying to open a new 500-600 seat middle school in the Greater Park Hill/Stapleton enrollment zone in Fall 2019.
University of Colorado researchers have had “unbelievable” results in a clinical trial for a type of leukemia, with 80% to 90% of patients going into complete remission.
